<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T14:57:19Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7689867" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7689867</identifier>
        <datestamp>2020-12-08</datestamp>
        <setSpec>blackwellopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Bone Miner Res</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Bone Miner Res</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)1523-4681</journal-id>
              <journal-id journal-id-type="publisher-id">JBMR</journal-id>
              <journal-title-group>
                <journal-title>Journal of Bone and Mineral Research</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0884-0431</issn>
              <issn pub-type="epub">1523-4681</issn>
              <publisher>
                <publisher-name>John Wiley &amp; Sons, Inc.</publisher-name>
                <publisher-loc>Hoboken, USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7689867</article-id>
              <article-id pub-id-type="pmcid">PMC7689867</article-id>
              <article-id pub-id-type="pmc-uid">7689867</article-id>
              <article-id pub-id-type="pmid">32511780</article-id>
              <article-id pub-id-type="pmid">32511780</article-id>
              <article-id pub-id-type="doi">10.1002/jbmr.4102</article-id>
              <article-id pub-id-type="publisher-id">JBMR4102</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Gene‐Metabolite Network Linked to Inhibited Bioenergetics in Association With Spaceflight‐Induced Loss of Male Mouse Quadriceps Muscle</article-title>
                <alt-title alt-title-type="right-running-head">MULTIOMICS ANALYSIS OF SPACEFLOWN MOUSE QUADRICEPS</alt-title>
                <alt-title alt-title-type="left-running-head">Chakraborty et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jbmr4102-cr-0001" contrib-type="author">
                  <name>
                    <surname>Chakraborty</surname>
                    <given-names>Nabarun</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7883-2013</contrib-id>
                  <xref ref-type="aff" rid="jbmr4102-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jbmr4102-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0002" contrib-type="author">
                  <name>
                    <surname>Waning</surname>
                    <given-names>David L</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3858-7623</contrib-id>
                  <xref ref-type="aff" rid="jbmr4102-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0003" contrib-type="author">
                  <name>
                    <surname>Gautam</surname>
                    <given-names>Aarti</given-names>
                  </name>
                  <xref ref-type="aff" rid="jbmr4102-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0004" contrib-type="author">
                  <name>
                    <surname>Hoke</surname>
                    <given-names>Allison</given-names>
                  </name>
                  <xref ref-type="aff" rid="jbmr4102-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="jbmr4102-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0005" contrib-type="author">
                  <name>
                    <surname>Sowe</surname>
                    <given-names>Bintu</given-names>
                  </name>
                  <xref ref-type="aff" rid="jbmr4102-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="jbmr4102-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0006" contrib-type="author">
                  <name>
                    <surname>Youssef</surname>
                    <given-names>Dana</given-names>
                  </name>
                  <xref ref-type="aff" rid="jbmr4102-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="jbmr4102-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0007" contrib-type="author">
                  <name>
                    <surname>Butler</surname>
                    <given-names>Stephan</given-names>
                  </name>
                  <xref ref-type="aff" rid="jbmr4102-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jbmr4102-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0008" contrib-type="author">
                  <name>
                    <surname>Savaglio</surname>
                    <given-names>Michael</given-names>
                  </name>
                  <xref ref-type="aff" rid="jbmr4102-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0009" contrib-type="author">
                  <name>
                    <surname>Childress</surname>
                    <given-names>Paul J</given-names>
                  </name>
                  <xref ref-type="aff" rid="jbmr4102-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0010" contrib-type="author">
                  <name>
                    <surname>Kumar</surname>
                    <given-names>Raina</given-names>
                  </name>
                  <xref ref-type="aff" rid="jbmr4102-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0011" contrib-type="author">
                  <name>
                    <surname>Moyler</surname>
                    <given-names>Candace</given-names>
                  </name>
                  <xref ref-type="aff" rid="jbmr4102-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="jbmr4102-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0012" contrib-type="author">
                  <name>
                    <surname>Dimitrov</surname>
                    <given-names>George</given-names>
                  </name>
                  <xref ref-type="aff" rid="jbmr4102-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jbmr4102-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0013" contrib-type="author">
                  <name>
                    <surname>Kacena</surname>
                    <given-names>Melissa A</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7293-0088</contrib-id>
                  <xref ref-type="aff" rid="jbmr4102-aff-0005">
                    <sup>5</sup>
                  </xref>
                  <xref ref-type="aff" rid="jbmr4102-aff-0006">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="jbmr4102-cr-0014" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Hammamieh</surname>
                    <given-names>Rasha</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8643-6232</contrib-id>
                  <xref ref-type="aff" rid="jbmr4102-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <address>
                    <email>asha.hammamieh1.civ@mail.mil</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="jbmr4102-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">The Geneva Foundation</named-content>
                <institution>Walter Reed Army Institute of Research</institution>
                <city>Silver Spring</city>
                <named-content content-type="country-part">MD</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jbmr4102-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Medical Readiness Systems Biology</named-content>
                <institution>Walter Reed Army Institute of Research</institution>
                <city>Silver Spring</city>
                <named-content content-type="country-part">MD</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jbmr4102-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <institution>Penn State College of Medicine</institution>
                <city>Hershey</city>
                <named-content content-type="country-part">PA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jbmr4102-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Oak Ridge Institute for Science and Education (ORISE)</named-content>
                <institution>Walter Reed Army Institute of Research</institution>
                <city>Silver Spring</city>
                <named-content content-type="country-part">MD</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jbmr4102-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Department of Orthopaedic Surgery</named-content>
                <institution>Indiana University School of Medicine</institution>
                <city>Indianapolis</city>
                <named-content content-type="country-part">IN</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jbmr4102-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <institution>Richard L. Roudebush VA Medical Center</institution>
                <city>Indianapolis</city>
                <named-content content-type="country-part">IN</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>Address correspondence to: Rasha Hammamieh, PhD, Medical Readiness Systems Biology, Walter Reed Army Institute of Research, 568 Doughten Drive, Fort Detrick, MD 21702‐5010 USA. E‐mail: <email>asha.hammamieh1.civ@mail.mil</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>30</day>
                <month>7</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>10</month>
                <year>2020</year>
              </pub-date>
              <volume>35</volume>
              <issue>10</issue>
              <issue-id pub-id-type="doi">10.1002/jbmr.v35.10</issue-id>
              <fpage>2049</fpage>
              <lpage>2057</lpage>
              <history>
                <date date-type="received">
                  <day>21</day>
                  <month>3</month>
                  <year>2020</year>
                </date>
                <date date-type="rev-recd">
                  <day>21</day>
                  <month>5</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>01</day>
                  <month>6</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright">&#x000a9; 2020 American Society for Bone and Mineral Research<copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2020 The Authors. <italic>Journal of Bone and Mineral Research</italic> published by American Society for Bone and Mineral Research.</copyright-statement>
                <license license-type="creativeCommonsBy">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JBMR-35-2049.pdf"/>
              <abstract>
                <title>ABSTRACT</title>
                <p>Prolonged residence of mice in spaceflight is a scientifically robust and ethically ratified model of muscle atrophy caused by continued unloading. Under the Rodent Research Program of the National Aeronautics and Space Administration (NASA), we assayed the large‐scale mRNA and metabolomic perturbations in the quadriceps of C57BL/6j male mice that lived in spaceflight (FLT) or on the ground (control or CTR) for approximately 4 weeks. The wet weights of the quadriceps were significantly reduced in FLT mice. Next‐generation sequencing and untargeted mass spectroscopic assays interrogated the gene‐metabolite landscape of the quadriceps. A majority of top‐ranked differentially suppressed genes in FLT encoded proteins from the myosin or troponin families, suggesting sarcomere alterations in space. Significantly enriched gene‐metabolite networks were found linked to sarcomeric integrity, immune fitness, and oxidative stress response; all inhibited in space as per in silico prediction. A significant loss of mitochondrial DNA copy numbers in FLT mice underlined the energy deprivation associated with spaceflight‐induced stress. This hypothesis was reinforced by the transcriptomic sequencing–metabolomics integrative analysis that showed inhibited networks related to protein, lipid, and carbohydrate metabolism, and adenosine triphosphate (ATP) synthesis and hydrolysis. Finally, we discovered important upstream regulators, which could be targeted for next‐generation therapeutic intervention for chronic disuse of the musculoskeletal system. © 2020 The Authors. <italic>Journal of Bone and Mineral Research</italic> published by American Society for Bone and Mineral Research.</p>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jbmr4102-kwd-0001">ANIMAL MODEL</kwd>
                <kwd id="jbmr4102-kwd-0002">METABOLISM</kwd>
                <kwd id="jbmr4102-kwd-0003">SKELETAL MUSCLE</kwd>
                <kwd id="jbmr4102-kwd-0004">SYSTEMS BIOLOGY</kwd>
                <kwd id="jbmr4102-kwd-0005">TISSUE SIGNALING</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institutes of Health </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>T32 DK007519</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>Department of Defense </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100000005</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>U.S. Army </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100006751</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>
                    <institution-wrap>
                      <institution>School of Medicine </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100008246</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0005">
                  <funding-source>
                    <institution-wrap>
                      <institution>Indiana University </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100006733</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0006">
                  <funding-source>
                    <institution-wrap>
                      <institution>U.S. Army Medical Research and Materiel Command </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100000182</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0007">
                  <funding-source>
                    <institution-wrap>
                      <institution>Orthopaedic Trauma Association </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100013769</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0008">
                  <funding-source>
                    <institution-wrap>
                      <institution>Ralph W. and Grace M. Showalter Research Trust Fund </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100007114</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>DK007519</award-id>
                  <award-id>T32</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="2"/>
                <page-count count="9"/>
                <word-count count="7493"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>October 2020</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.4 mode:remove_FC converted:26.11.2020</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body id="jbmr4102-body-0001">
            <sec id="jbmr4102-sec-0001">
              <title>Introduction</title>
              <p>Extended periods of skeletal muscle disuse that is prevalent in many populations such as the elderly,<sup>(</sup>
<xref rid="jbmr4102-bib-0001" ref-type="ref"><sup>1</sup></xref>
<sup>)</sup> the injured,<sup>(</sup>
<xref rid="jbmr4102-bib-0002" ref-type="ref"><sup>2</sup></xref>
<sup>)</sup> and astronauts<sup>(</sup>
<xref rid="jbmr4102-bib-0003" ref-type="ref"><sup>3</sup></xref>
<sup>)</sup> lead to significant losses of muscle mass, morphology, and strength. In bed rest studies simulating unloading condition, losses of 6% to 11% of quadriceps mass and power have been reported in as little as 3 weeks.<sup>(</sup>
<xref rid="jbmr4102-bib-0004" ref-type="ref"><sup>4</sup></xref>
<sup>)</sup> For spaceflight, both long‐term (up to 6 months) and short‐term (1 to 2 weeks) space missions reported losses in quadriceps volume of up to 15%, with similar numbers reported for loss of strength.<sup>(</sup>
<xref rid="jbmr4102-bib-0005" ref-type="ref"><sup>5</sup></xref>, <xref rid="jbmr4102-bib-0006" ref-type="ref"><sup>6</sup></xref>
<sup>)</sup> In support, significant atrophy of rodent quadriceps was observed after a 30‐day‐long space mission<sup>(</sup>
<xref rid="jbmr4102-bib-0007" ref-type="ref"><sup>7</sup></xref>
<sup>)</sup> and in 14‐day‐long and 21‐day‐long hindlimb unloading studies (to model disuse).<sup>(</sup>
<xref rid="jbmr4102-bib-0008" ref-type="ref"><sup>8</sup></xref>
<sup>)</sup> A common theme across these types of studies is that the thigh muscles which include quadriceps are typically affected by unloading. The dose‐dependent effect of unloading is somewhat alleviate in astronauts, because they are required to follow various exercise protocols on any space mission in which they participate.<sup>(</sup>
<xref rid="jbmr4102-bib-0009" ref-type="ref"><sup>9</sup></xref>
<sup>)</sup> This suggests that the atrophy in space could be much greater than that observed in bed rest if the astronauts were able to remain inactive for extended periods in space. Clinical studies using astronauts are further limited due to the small sample size.</p>
              <p>Rodent research at the International Space Station (ISS) is a comparatively new undertaking. The National Aeronautics and Space Administration (NASA)’s rodent spaceflight hardware is capable of housing only 40 mice at a time with certain provisions as necessary to conduct such research in space. Taking full advantages of sample size and other means offered at the ISS, our project, named as Rodent Research 4 (<ext-link ext-link-type="uri" xlink:href="https://www.nasa.gov/ames/research/space-biosciences/rodent-research-4-spacex-10">https://www.nasa.gov/ames/research/space‐biosciences/rodent‐research‐4‐spacex‐10</ext-link>), housed male mice in NASA’s hardware at the ISS for the first time. A ground‐based control study (CTR) used the same rodent habitat conditions, mimicking all the procedures performed at ISS, offset by 5 days. Wet weights of various muscles underscored the detrimental effects of spaceflight‐induced stress on muscle volume. Quadriceps muscles, previously identified for displaying significant impacts from spaceflight and its simulating environments,<sup>(</sup>
<xref rid="jbmr4102-bib-0003" ref-type="ref"><sup>3</sup></xref>, <xref rid="jbmr4102-bib-0004" ref-type="ref"><sup>4</sup></xref>, <xref rid="jbmr4102-bib-0005" ref-type="ref"><sup>5</sup></xref>, <xref rid="jbmr4102-bib-0006" ref-type="ref"><sup>6</sup></xref>
<sup>)</sup> were selected to divulge the molecular underpinnings of the muscle loss. A deep gene sequencing readout suggested mitochondrial dysfunction; hence, the global metabolomics of quadriceps was conducted to examine the bioenergetics profile. Functional analysis trained toward muscular atrophy found comprehensive inhibition of key molecular networks essential for normal muscular functions. In addition, we determined a set of quadriceps‐specific upstream regulators, which could have significant clinical interest, because a large number of genes and their biofunctions can be systematically controlled via targeting a single upstream regulator.<sup>(</sup>
<xref rid="jbmr4102-bib-0010" ref-type="ref"><sup>10</sup></xref>
<sup>)</sup>
</p>
            </sec>
            <sec id="jbmr4102-sec-0002">
              <title>Materials and Methods</title>
              <sec id="jbmr4102-sec-0003">
                <title>Ethics statement</title>
                <p>All animal experiments were approved by the ISS and Kennedy Space Center (KSC) Institutional Animal Care and Use Committees (IACUCs), and were performed in facilities accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). This research complied with the Animal Welfare Act and implementing Animal Welfare Regulations, the Public Health Service Policy on Humane Care and Use of Laboratory Animal.</p>
              </sec>
              <sec id="jbmr4102-sec-0004">
                <title>Animal handling</title>
                <p>Details of the animal handling protocols are presented in the online Supplementary Data. Briefly, 9‐week‐old, male C57BL/6j mice were used for this study. Cages of 10 mice were randomly selected to be housed on the ISS (spaceflight [FLT]) or at KSC (CTR). The ground control study at KSC began with a 5‐day offset. Both FLT and CTR mice were housed under similar caging conditions including 12‐hour light/dark cycle and were provided with the same diet/water <italic>ad libitum</italic>. Mice were humanely euthanized 24 to 28 days post‐launch when the mice were ~13weeks of age. Five of 10 mice/group were reserved for imaging studies.<sup>(</sup>
<xref rid="jbmr4102-bib-0011" ref-type="ref"><sup>11</sup></xref>
<sup>)</sup> For the remaining five mice, the carcasses were snap‐frozen at –80°C. FLT samples were returned to Earth; and all samples were processed at the same time in the same laboratory. Therefore, a maximum of five mice/group were available for these studies. Four randomly selected FLT and CTR carcasses were used for omics analyses. The muscle tissues were isolated and frozen at –80°C for further analysis.</p>
                <p>Upon retrieving the right leg quadriceps, extensor digitorum longus (EDL), and soleus muscle tissue from the freezer, their wet weights were recorded. Next, we proceeded with the quadriceps tissue for multiomics assay. The quadriceps was cryogenically homogenized using a Cryomill (Haan, Germany). An aliquot of the homogenate was allotted to extract DNA and RNA using the standard TRIzol (Invitrogen, Thermo Fisher Scientific, Wilmington, MA, USA) method. The copy number variation of mitochondrial DNA was measured using NovaQUANT (Novagen, Madison, WI, USA). For large‐scale mRNA sequencing, 2 × 150 cycles of paired‐end reads were generated in HiSeq4000 platform (Illumina, Inc., San Diego, CA, USA) following TruSeq stranded mRNA protocol. The reads were trimmed, normalized with the weighted trimmed mean of M‐values method and aligned to <italic>Mus musculus</italic> whole genome assembly (mm10; <ext-link ext-link-type="uri" xlink:href="https://genome.ucsc.edu/cgi-bin/hgGateway?db=mm10">https://genome.ucsc.edu/cgi-bin/hgGateway?db=mm10</ext-link>). The data file is uploaded at the Sequence Read Archive (SRA; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/">https://www.ncbi.nlm.nih.gov/sra/</ext-link>); submission ID: SUB6956586.</p>
                <p>A second aliquot of quadriceps homogenate was used for global metabolomics analysis using mass spectrometry performed on a Quadrupole Time‐of‐Flight (Q‐TOF) Premier mass spectrometer (Waters Corporation, Milford, MA, USA). The differentially expressed mass spectroscopy peaks were annotated using CEU Mass Mediator database (<ext-link ext-link-type="uri" xlink:href="http://ceumass.eps.uspceu.es/">http://ceumass.eps.uspceu.es/</ext-link>) and the molecules were screened based on the following guideline: (i) parts per million (ppm) error &lt;1; (ii) chemical formula comprised of the adducts: +H, −H, +Na, +K, +NH4, and −Cl; (iii) annotate by Human Metabolome Database (HMDB; <ext-link ext-link-type="uri" xlink:href="https://hmdb.ca/">https://hmdb.ca/</ext-link>); and (iv) chemical type of one of the following categories: (i) endogenous mammalian, (ii) drugs, (iii) toxicant, and (iv) reagents. The third aliquot was used for estimating the load of myosin protein using and ELISA kit from Abbexa (Cambridge, UK).</p>
                <p>The statistical analysis was performed using R scripts (R Foundation for Statistical Computing, Vienna, Austria; https://www.r‐project.org/) and GeneSping (Agilent Technologies, Santa Clara, CA, USA). The differentially expressed transcripts and metabolites were selected via moderate <italic>t</italic> test <italic>p</italic> &lt; .05. mRNA and metabolite co‐enriched networks were mined using Ingenuity Pathway Analysis (IPA) v01‐13 (QIAGEN, Inc., Hilden, Germany) and ImPala v12.<sup>(</sup>
<xref rid="jbmr4102-bib-0012" ref-type="ref"><sup>12</sup></xref>, <xref rid="jbmr4102-bib-0013" ref-type="ref"><sup>13</sup></xref>
<sup>)</sup> The networks were selected based on two criteria: (i) hypergeometric <italic>p</italic> &lt; .05; and (ii) number of molecules (gene and/or metabolite) &gt;5. <italic>Z</italic>‐score was used to define the regulations of networks; <italic>Z</italic>‐scores &gt;1.5 and &lt; −1.5 were considered activated or inhibited networks, respectively. To curate the upstream regulators of interest, we applied the following criteria: (i) the upstream regulator should either be differentially expressed gene (DEG) or differentially expressed metabolite (DEM); (ii) <italic>Z</italic>‐score &gt; |1.5|; and (iii) hypergeometric <italic>p</italic> &lt; .05.</p>
              </sec>
            </sec>
            <sec id="jbmr4102-sec-0005">
              <title>Results</title>
              <p>Cages of 10 male C57BL/6j mice at ~9 weeks of age were randomly assigned into FLT or CTR groups. FLT mice were launched in space and stayed there for nearly 4 weeks. Both groups were humanely euthanized in identical manners in spaceflight or on the ground (asynchronous 5 days) (Fig. <xref rid="jbmr4102-fig-0001" ref-type="fig">1<italic>A</italic>
</xref>). All the frozen carcasses were collected on Earth and the tissues were extracted within 20 min after undergoing minimum freeze‐thaw cycle. Omics assays were conducted on four randomly selected mice per group.</p>
              <fig fig-type="Fig" xml:lang="en" id="jbmr4102-fig-0001" orientation="portrait" position="float">
                <label>Fig 1</label>
                <caption>
                  <p>(<italic>A</italic>) The timeline of Rodent Research 4 (RR4). The timeline depicts how the research was planned around the launch (L) of space shuttle SpaceX‐10. The types of assays reported in this article are listed at the end. Timeline is not to scale. (<italic>B</italic>) The wet mass of quadriceps, soleus, and EDL. The bar and whisker plot represents the median weight values with the 10 to 90 percentile. The hashed and white boxes represents FLT and CTR mice cohorts, respectively. The significance level of changes was calculated using Student’s <italic>t</italic> test. (<italic>C</italic>) The regulation of myosin protein in FLT versus CTR mice. The bar and whisker plot presents the median values with 10 to 90 percentile. The reduction of OD<sub>450</sub> in FLT (white bar) in comparison to the CTR (hashed bar) was significant. (<italic>D</italic>) mtDNA CNV in FLT versus CTR mice. The <italic>y</italic> axis represents the ratio of CNs of mtDNA and nDNA. The bar and whisker plot presents the median values with 10 to 90 percentile. The significance level of changes was calculated using Student’s <italic>t</italic> test. BG = background; CN = copy number; CTR = control group on the ground; d = day; EDL = extensor digitorum longus; FLT = spaceflight; ISS = International Space Station; KSC = Kennedy Space Center; L = launch; m = months; mtDNA CNV = mitochondrial DNA copy number variation; nDNA = nuclear DNA; OD<sub>450</sub> = optical density at 450 nm; w = weeks.</p>
                </caption>
                <graphic id="nlm-graphic-1" xlink:href="JBMR-35-2049-g001"/>
              </fig>
              <p>Wet weights of the right leg quadriceps, soleus, and EDL muscles were decreased by 50% (<italic>p</italic> = .006), 36% (<italic>p</italic> = .095), and 23% (<italic>p</italic> = .015), respectively, in the FLT mice compared to CTR mice (Fig. <xref rid="jbmr4102-fig-0001" ref-type="fig">1<italic>B</italic>
</xref>). There was a significant (<italic>p</italic> &lt; .01, Student’s <italic>t</italic> test) reduction in the myosin load of quadriceps from FLT mice as compared to CTR mice, as evidenced by a decline of nearly 30% in the ELISA optical density measurement (Fig. <xref rid="jbmr4102-fig-0001" ref-type="fig">1<italic>C</italic>
</xref>). The mitochondrial DNA copy number variation (mtDNA CNV) assay found a significant sevenfold decrease of mtDNA CNs in FLT quadriceps in comparison to CTR quadriceps (<italic>p</italic> = .020, Student’s <italic>t</italic> test) (Fig. <xref rid="jbmr4102-fig-0001" ref-type="fig">1<italic>D</italic>
</xref>).</p>
              <p>Quality controlled mRNA reads of quadriceps tissue (Fig. <xref rid="jbmr4102-supitem-0002" ref-type="supplementary-material">S1</xref>) were successfully mapped onto 10,874 genes (~54% of whole mouse genes) with counts per million &gt;0.5 in all eight samples (<italic>n</italic> = 4/group × FLT and CTR). The detail of the data quality is narrated in the online Supplementary Data. There were 776 DEGs between FLT and CTR quadriceps, which included 378 upregulated and 398 downregulated genes. False discovery rate (FDR) correction yielded 19 genes that met the cutoff 0.1 (Table <xref rid="jbmr4102-tbl-0001" ref-type="table">1</xref>), whereas 14 of these 19 genes met the FDR cutoff of 0.05.</p>
              <table-wrap id="jbmr4102-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                <label>Table 1</label>
                <caption>
                  <p>The 19 Quadriceps‐Specific Genes, Differentially Expressed Between the Spaceflight (FLT) and Ground Control (CTR) Mice, Meeting FDR Cutoff 0.1</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col align="left" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="left" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <thead valign="bottom">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Gene symbol</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">Log<sub>2</sub>(fold change)</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">
                        <italic>p</italic>
                      </th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">FDR</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">Entrez gene name</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">Location of encoded protein</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">Type of encoded protein</th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TNNT1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−3.63</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.72E‐08</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.87E‐04</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Troponin T1, slow skeletal type</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Cytoplasm</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MYH7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−5.23</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.25E‐07</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">6.79E‐04</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Myosin heavy chain 7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Cytoplasm</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Enzyme</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TNNC1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−3.92</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.27E‐07</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">8.90E‐04</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Troponin C1, slow skeletal and cardiac type</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Cytoplasm</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TNNI1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−4.48</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.60E‐07</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">8.90E‐04</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Troponin I1, slow skeletal type</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Cytoplasm</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MYL2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−3.34</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.66E‐06</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.58E‐03</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Myosin light chain 2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Cytoplasm</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MYLK4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−1.46</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.48E‐06</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.58E‐03</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Myosin light chain kinase family member 4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Cytoplasm</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Kinase</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">PTPN3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−1.77</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.63E‐06</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.58E‐03</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Protein tyrosine phosphatase, non‐receptor type 3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Cytoplasm</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Phosphatase</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TPPP3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.34</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.12E‐05</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.88E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Tubulin polymerization promoting protein family member 3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Cytoplasm</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">PER3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−1.53</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.71E‐05</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.28E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Period circadian regulator 3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Nucleus</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">AVIL</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.26</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">4.12E‐05</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.78E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Advillin</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Plasma membrane</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">GOLGA7B</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.45</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.91E‐05</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.78E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Golgin A7 family member B</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">LRRC30</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.02</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">4.52E‐05</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.78E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Leucine rich repeat containing 30</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MYOZ2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−2.24</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">4.40E‐05</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.78E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Myozenin 2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">4832428D23Rik</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.90</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5.57E‐05</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">4.33E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MYH2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−1.47</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">7.76E‐05</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5.62E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Myosin heavy chain 2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Cytoplasm</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Enzyme</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TRIOBP</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.87</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.12E‐04</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">7.61E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">TRIO and F‐actin binding protein</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Nucleus</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">PER2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−2.43</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.31E‐04</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">8.36E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Period circadian regulator 2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Nucleus</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Transcription regulator</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">PFN2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−0.85</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.42E‐04</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">8.36E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Profilin 2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Cytoplasm</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Enzyme</td>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">DCAF4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.88</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.68E‐04</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">9.60E‐02</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">DDB1 and CUL4 associated factor 4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Nucleus</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">Other</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot id="jbmr4102-ntgp-0002">
                  <fn id="jbmr4102-note-0002">
                    <p>We report the gene symbol, gene name, FDR, and corresponding <italic>p</italic> values. The location and type of the protein encoded by the gene is reported as well. There are four genes (ie, MYH7, MYL2, MYLK4, and MYH2) in this list that encode proteins related to myosin family. Similarly, there are three genes (ie, TNNT1, TNNC1, and TNN1) in this list that encode proteins related to the troponin family. These are the two most popular protein families in this list.</p>
                    <p>NA = not applicable.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>Mass spectrometry analysis of quadriceps tissues identified 740 DEMs between FLT and CTR, which included 440 downregulated and 300 upregulated metabolites. None of these metabolites met FDR correction.</p>
              <p>Biological network analysis was carried out using those DEGs and which met a moderate <italic>t</italic> test <italic>p</italic> &lt; .05. There were 23 significantly enriched (Fisher’s hypergeometric <italic>t</italic> test <italic>p</italic> &lt; .05) and significantly regulated (<italic>Z</italic>‐score &gt; |1.5|) canonical networks (Table <xref rid="jbmr4102-supitem-0003" ref-type="supplementary-material">S1</xref>). The eukaryotic initiation factor 2 (eIF2) signaling networks emerged as the most significantly activated network (<italic>Z</italic>‐score &gt; 1.5) in FLT mice compared to CTR quadriceps. In addition, there were 21 canonical networks significantly inhibited in FLT mice (<italic>Z</italic>‐score &lt; −1.5). Integrin signaling and nuclear factor erythroid 2–related factor 2 (Nrf2)‐mediated oxidative stress response signaling networks were the two most inhibited canonical networks, which were enriched by 19 and 23 DEGs, respectively.</p>
              <p>The canonical network analysis prompted us to construct six de novo biological networks, which potentially play key roles in spaceflight‐induced muscle loss, namely (i) protein metabolism, (ii) lipid metabolism, (iii) carbohydrate metabolism, (iv) muscle health, (v) inflammation, and (vi) mitochondrial dysfunction (Fig. <xref rid="jbmr4102-fig-0002" ref-type="fig">2<italic>A</italic>
</xref>, Table <xref rid="jbmr4102-supitem-0003" ref-type="supplementary-material">S2</xref>). All of these networks were significantly enriched by the hypergeometric test (<italic>p</italic> &lt; .05). Significantly enriched subnetworks (<italic>p</italic> &lt; .05) linked to these individual noncanonical networks were mined and their regulation status (activated versus inhibited) were computed by molecule activity predictor (MAP) in IPA.</p>
              <fig fig-type="Fig" xml:lang="en" id="jbmr4102-fig-0002" orientation="portrait" position="float">
                <label>Fig 2</label>
                <caption>
                  <p>(<italic>A</italic>) Four noncanonical networks of interest, namely metabolic dysfunction, muscle health, inflammation, and mitochondrial dysregulation. The metabolic dysfunction includes dysfunctions in metabolism of carbohydrate, lipid, and protein, respectively. The Venn diagram at the center suggests the association among these four noncanonical functions, whereas the numbers inside the diagram represent overlapping DEGs and DEMs across the networks. The subnetworks under each noncanonical network are listed next to the color‐coded boxes representing their significance of enrichment calculated by hypergeometric <italic>t</italic> test. The color code of the range of log<sub>10</sub>(<italic>p</italic> values) is shown at the left bottom corner; two extreme points, namely the dark blue and light blue, represented by log<sub>10</sub>(<italic>p</italic> values) = 10 and 100, respectively. The numbers of molecules (DEGs + DECs) enriching each network are represented by different circles next to the columns of log<sub>10</sub>(<italic>p</italic> values). Circles bordered by broken line, solid line, double line, solid line + filled with hashed lines, and solid line + filled solid color represent the sample sizes &lt;25, 50, 75, 100, and 125, respectively. The regulation status (activated versus inhibited) of the networks were computed by MAP algorithm. Only the activated networks were marked by upward red arrows; the remaining unmarked networks were inhibited as per MAP algorithm. (<italic>B</italic>) Bioenergetics networks inhibited in spaceflight. The oval, hexagonal, and rectangular shaped nodes represent gene, metabolite, and biofunction, respectively. Red color means upregulated and green means downregulated in spaceflight compared to controls. All of the biofunctions noted inside the clear rectangles were inhibited in spaceflight as predicted by the MAP algorithm supplied by IPA. The arrow‐headed and open‐ended edges represent the regulative and associative relationship between two connecting nodes. (<italic>C</italic>) A network cluster linked to cell survival and proliferation. The oval‐shaped and rectangular nodes are represented by gene and pathways, respectively. SOCS1 gene is a significant upstream regulator, which was upregulated in space as marked by red upward arrow. This regulator inhibits the JAK/STAT pathway as represented by the blunt headed edge between SOCS1 and JAK/STAT pathway. All the networks in this figure were inhibited in space as predicted by MAP. Their regulation status are shown by blue downward arrow. The arrow‐headed edges between the networks represent the activating relationships. (<italic>D</italic>) Hierarchical clustering of DEGs linked to the networks contributing to cell survival and proliferation. The genes enriching at least two of the five networks are clustered by Euclidean calculations. The color code of the gene regulation is in the left bottom. Deep red and blue colors represent upregulation and downregulation, respectively, whereas yellow represent no change. DEG = differentially expressed gene; DEMs = differentially expressed metabolites; IPA = Ingenuity Pathway Analysis; MAP = molecule activity predictor.</p>
                </caption>
                <graphic id="nlm-graphic-3" xlink:href="JBMR-35-2049-g002"/>
              </fig>
              <p>The protein metabolism network was enriched by 113 DEGs and seven DEMs that co‐constructed three key subnetworks: protein synthesis, catabolism, and translation; all three were predicted to be inhibited in FLT mice by the MAP algorithm. The carbohydrate metabolism network was enriched by 105 DEGs and 12 DEMs that co‐enriched the subnetworks, such as the uptake and quantity of carbohydrate, glucose (all inhibited in FLT), and glucose metabolism disorder network (activated in FLT). Enriched by 119 DEGs and 28 DEMs, a lipid metabolism network was built upon nine subnetworks including lipid synthesis and concentrations; both were inhibited in FLT mice as per our in silico prediction.</p>
              <p>We curated 108 DEGs and three DEMs that are directly linked to muscle functions. Its subnetworks such as muscle formation, contraction, and differentiation were inhibited, but the proliferation network of the muscle cell was activated in FLT as per the MAP algorithm. In the context of muscular contraction, we further investigated the gene level activities of the calcium channel: they are composed of 28 DEGs and 17 DEMs (Table <xref rid="jbmr4102-supitem-0003" ref-type="supplementary-material">S2</xref>
<italic>D</italic>), and its subnetworks linked to flux and calcium ion quantity were inhibited in FLT in comparison to CTR. The inflammation network was enriched by 114 DEGs and 39 DEMs. This overarching network assembled a large set of inhibited subnetworks in spaceflight that included the activation and proliferation of lymphocytes, leukocytes, and phagocytes, and the synthesis of nitric oxide. Finally, the network linked to mitochondrial function was enriched by 42 DEGs and 18 DEMs (Fig. <xref rid="jbmr4102-fig-0002" ref-type="fig">2<italic>B</italic>
</xref>). Its subnetworks included synthesis and hydrolysis of ATP, generation of reactive oxygen species and nitric oxide, and mitochondrial permeability. All of these subnetworks were inhibited in FLT mice as predicted by the MAP algorithm.</p>
              <p>Table <xref rid="jbmr4102-tbl-0002" ref-type="table">2</xref> enlists six upstream regulators; the regulation status (activated versus inhibited) of the cluster of DEGs and DEMs controlled by each regulator is quantified by the <italic>Z</italic>‐score. Genes STAT5B, SMAD3, and HSF1 encode transcription‐regulating proteins. Monoethylhexyl phthalate (MEHP) is a chemical toxicant, which was upregulated in FLT and potentially inhibited a cluster of 16 DEGs. SOCS1 is a downregulated gene in FLT and one of the top‐ranked upstream inhibitors regulating nine DEGs and one DEM. Table S3 enlisted those differentially expressed genes, which are controlled by these upstream regulators.</p>
              <table-wrap id="jbmr4102-tbl-0002" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                <label>Table 2</label>
                <caption>
                  <p>List of Upstream Regulators of Interest</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <thead valign="bottom">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Upstream regulator</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">Name</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">Log<sub>2</sub>(fold change)</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1"><italic>Z</italic>‐score</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">
                        <italic>p</italic>
                      </th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">Molecules to regulate (gene/metabolite)</th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">SOCS1</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Suppressor of cytokine signaling 1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.02</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−2.14</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">.02</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">9/1</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">STAT5B</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Signal transducer and activator of transcription 5B</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.64</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.70</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5.52E‐10</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">33/1</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">SMAD3</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Mothers against decapentaplegic homolog 3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.50</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1.86</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">.05</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">12/3</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">HSF1</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Heat shock transcription factor 1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.40</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−1.67</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.12E‐05</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">19/1</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">MEHP</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Mono‐(2‐ethyl hexyl) phthalate</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.25</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−2.50</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.70E‐04</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">16/0</td>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <td align="left" valign="top" rowspan="1" colspan="1">PLAU</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">Plasminogen activator</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−0.84</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">−1.67</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">.04</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5/1</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot id="jbmr4102-ntgp-0003">
                  <fn id="jbmr4102-note-0003">
                    <p>These upstream regulators are sorted based on their fold changes (FLT/CTR) transformed to log scale base 2.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
            </sec>
            <sec id="jbmr4102-sec-0006">
              <title>Discussion</title>
              <p>Spaceflight is an environment encompassing a set of atypical stress components such as weightlessness or microgravity, low‐dose radiation, and disrupted circadian rhythm. Recent studies further linked spaceflight to immune deficiencies, metabolic syndrome, bioenergetics dysfunction, and vascular remodeling.<sup>(</sup>
<xref rid="jbmr4102-bib-0014" ref-type="ref"><sup>14</sup></xref>, <xref rid="jbmr4102-bib-0015" ref-type="ref"><sup>15</sup></xref>, <xref rid="jbmr4102-bib-0016" ref-type="ref"><sup>16</sup></xref>, <xref rid="jbmr4102-bib-0017" ref-type="ref"><sup>17</sup></xref>, <xref rid="jbmr4102-bib-0018" ref-type="ref"><sup>18</sup></xref>
<sup>)</sup> Each of these factors individually has shown detrimental effects on musculoskeletal health; in this perspective, this Rodent Research 4 (RR4) project presented us a unique opportunity to investigate the cumulative effects of all of these stress factors on muscle fitness. Our previous studies<sup>(</sup>
<xref rid="jbmr4102-bib-0011" ref-type="ref"><sup>11</sup></xref>, <xref rid="jbmr4102-bib-0019" ref-type="ref"><sup>19</sup></xref>
<sup>)</sup> showed that femoral and tibial trabecular bone volume was significantly reduced during spaceflight. Supplementing this knowledge, we reported the reduction of the wet mass of quadriceps, EDL, and soleus muscles in FLT compared to CTR mice. Extending previous reports,<sup>(</sup>
<xref rid="jbmr4102-bib-0003" ref-type="ref"><sup>3</sup></xref>, <xref rid="jbmr4102-bib-0004" ref-type="ref"><sup>4</sup></xref>, <xref rid="jbmr4102-bib-0005" ref-type="ref"><sup>5</sup></xref>, <xref rid="jbmr4102-bib-0006" ref-type="ref"><sup>6</sup></xref>
<sup>)</sup> present multiomics investigations targeted quadriceps, a major weight‐bearing muscle. Furthermore, the larger biomass of quadriceps in comparison to soleus and EDL was proportionate to the demand of the tissue size needed for multiomics undertakings.</p>
              <p>A small but mounting number of studies have been focused on spaceflight‐related muscular atrophy; however, these results have often failed to capture the comprehensive picture due to the lack sufficient sample size<sup>(</sup>
<xref rid="jbmr4102-bib-0020" ref-type="ref"><sup>20</sup></xref>
<sup>)</sup> and targeted or localized approaches.<sup>(</sup>
<xref rid="jbmr4102-bib-0007" ref-type="ref"><sup>7</sup></xref>
<sup>)</sup> Bridging the gap, we used 10 mice/group for phenotypic observation and a randomly selected four mice/group were investigated for large‐scale transcript sequencing‐metabolite regulations. Systems integration of gene‐metabolite profiles have emerged as a successful approach to understand the temporal profile of a series of molecular events.<sup>(</sup>
<xref rid="jbmr4102-bib-0013" ref-type="ref"><sup>13</sup></xref>, <xref rid="jbmr4102-bib-0021" ref-type="ref"><sup>21</sup></xref>
<sup>)</sup>
</p>
              <p>Overall, our observations revealed that the genes promoting muscle atrophy and protein degradation<sup>(</sup>
<xref rid="jbmr4102-bib-0022" ref-type="ref"><sup>22</sup></xref>, <xref rid="jbmr4102-bib-0023" ref-type="ref"><sup>23</sup></xref>
<sup>)</sup> were upregulated in space, while those genes which encode proteins linked to muscle fiber differentiation,<sup>(</sup>
<xref rid="jbmr4102-bib-0020" ref-type="ref"><sup>20</sup></xref>, <xref rid="jbmr4102-bib-0022" ref-type="ref"><sup>22</sup></xref>, <xref rid="jbmr4102-bib-0024" ref-type="ref"><sup>24</sup></xref>
<sup>)</sup> calcium channel operation,<sup>(</sup>
<xref rid="jbmr4102-bib-0025" ref-type="ref"><sup>23</sup></xref>
<sup>)</sup> and muscular functions<sup>(</sup>
<xref rid="jbmr4102-bib-0023" ref-type="ref"><sup>23</sup></xref>, <xref rid="jbmr4102-bib-0026" ref-type="ref"><sup>26</sup></xref>
<sup>)</sup> became downregulated. In particular, spaceflight inhibited or altered the expression of the genes and proteins related to the myosin heavy chain (MYH) family that typically contributes to the formation and function of skeletal muscle,<sup>(</sup>
<xref rid="jbmr4102-bib-0027" ref-type="ref"><sup>27</sup></xref>
<sup>)</sup> and previously identified as the marker of compromised muscular functions triggered by spaceflight.<sup>(</sup>
<xref rid="jbmr4102-bib-0028" ref-type="ref"><sup>28</sup></xref>, <xref rid="jbmr4102-bib-0029" ref-type="ref"><sup>29</sup></xref>
<sup>)</sup> Our mRNA deep‐sequencing approach showed reduced expressions of four genes related to myosin and another three related to troponin in the FLT group compared to the CTR group. A potential negative impact of spaceflight on sarcomere architecture was further highlighted by the inhibited signaling of the integrin and actin cytoskeleton that typically provides the structural stability of muscle<sup>(</sup>
<xref rid="jbmr4102-bib-0030" ref-type="ref"><sup>30</sup></xref>
<sup>)</sup> and facilitates muscular contraction,<sup>(</sup>
<xref rid="jbmr4102-bib-0031" ref-type="ref"><sup>31</sup></xref>
<sup>)</sup> respectively. In this context, the inhibited molecular network in FLT linked to the operation of the calcium ion channel is worth noting. Therefore, it is conceivable that the FLT mice would have poorly functioning, or a reduced quantity of contractile units, in their skeletal muscle fibers. However, we could not measure sarcomeres from our mice because of tissue preparation limitations during spaceflight. Additionally, our study is limited by not recording body weights of the mice. Measuring body weights in spaceflight was infeasible. We decided against weighing the frozen carcasses of mice on the ground for several reasons. First, the possible differential amount of liquid crystallization in the carcass could confound the result. Second, the amount of blood withdrawn by cardiac puncture by the astronauts varied significantly from mouse to mouse. Third, half of the mice had their hindlimb removed. Finally, our first priority was to rapidly extract the tissues to minimize the freeze‐thaw cycle. Nevertheless, previous studies reported insignificant change in body weights of mice after space travels<sup>(</sup>
<xref rid="jbmr4102-bib-0032" ref-type="ref"><sup>32</sup></xref>, <xref rid="jbmr4102-bib-0033" ref-type="ref"><sup>33</sup></xref>
<sup>)</sup> and after exposing mice to hindlimb unloading on the ground.<sup>(</sup>
<xref rid="jbmr4102-bib-0034" ref-type="ref"><sup>34</sup></xref>
<sup>)</sup>
</p>
              <p>Altered calcium usage, decreased mtDNA CNs, and inhibited tricarboxylic acid (TCA) cycles are likely to converge to impair mitochondrial function, because these are causally related to essential cellular metabolism.<sup>(</sup>
<xref rid="jbmr4102-bib-0035" ref-type="ref"><sup>35</sup></xref>, <xref rid="jbmr4102-bib-0036" ref-type="ref"><sup>36</sup></xref>
<sup>)</sup> The mitochondrial dysfunction in space could explain the dysregulation occurring at the level of the sarcomeres that ultimately contributes to significant muscle loss. Typically, the muscular efficiency and endurance is dependent on carbohydrate metabolism, which is supported by the fatty acid metabolism as the secondary source of energy, while anaerobic glycolysis provides energy during intensive activities.<sup>(</sup>
<xref rid="jbmr4102-bib-0037" ref-type="ref"><sup>37</sup></xref>, <xref rid="jbmr4102-bib-0038" ref-type="ref"><sup>38</sup></xref>
<sup>)</sup> Our gene‐metabolite integrative analysis revealed that all of these energy sources, required for proper muscular functions, were inhibited in the spaceflight, potentially driving the host to a major energy‐deprived state.<sup>(</sup>
<xref rid="jbmr4102-bib-0039" ref-type="ref"><sup>39</sup></xref>
<sup>)</sup>
</p>
              <p>This energy‐deprived condition could be associated with the impairment of additional energy‐expensive mechanisms. One foremost energy‐expensive mechanism, namely the host’s immune response, was associated with a list of significantly inhibited canonical networks in FLT mice having Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signal at the hub of C‐X‐C chemokine receptor type 4 (CXCR‐4)‐signaling, FGF‐signaling, NGF‐signaling, and STAT3‐signaling networks.<sup>(</sup>
<xref rid="jbmr4102-bib-0040" ref-type="ref"><sup>40</sup></xref>
<sup>)</sup> Immunodeficiency in FLT mice was further highlighted as the majority of upstream regulators that encode proteins to act at the immunity checkpoints (ie, SOCS1<sup>(</sup>
<xref rid="jbmr4102-bib-0041" ref-type="ref"><sup>41</sup></xref>
<sup>)</sup> and SMAD3<sup>(</sup>
<xref rid="jbmr4102-bib-0042" ref-type="ref"><sup>42</sup></xref>
<sup>)</sup>) or to mediate mitochondrial operations (ie, MEHP<sup>(</sup>
<xref rid="jbmr4102-bib-0043" ref-type="ref"><sup>43</sup></xref>
<sup>)</sup>). Given the fact that SOCS1 is an established negative regulator of the JAK/STAT network,<sup>(</sup>
<xref rid="jbmr4102-bib-0044" ref-type="ref"><sup>42</sup></xref>
<sup>)</sup> and hence its downstream pathways,<sup>(</sup>
<xref rid="jbmr4102-bib-0040" ref-type="ref"><sup>40</sup></xref>
<sup>)</sup> spaceflight appears to inhibit a large cascade of molecular networks which compromise the immune fitness by upregulating SOCS1 gene expression. The relevant network cluster regulated by SOCS1<sup>(</sup>
<xref rid="jbmr4102-bib-0045" ref-type="ref"><sup>45</sup></xref>
<sup>)</sup> is displayed in Fig. <xref rid="jbmr4102-fig-0002" ref-type="fig">2<italic>C</italic>
</xref> and hierarchical clustering of the DEGs enriching this network cluster is shown in Fig. <xref rid="jbmr4102-fig-0002" ref-type="fig">2<italic>D</italic>
</xref>.</p>
              <p>However, the question remains as to whether the disuse is the cause or consequence of shifting the expressions of those molecules, which promotes energy deprivation. In either case, it is also notable that our data on the immune functions in spaceflight correlated well with previous works that have associated these immunodeficiencies to energy deprivation in space.<sup>(</sup>
<xref rid="jbmr4102-bib-0012" ref-type="ref"><sup>12</sup></xref>, <xref rid="jbmr4102-bib-0016" ref-type="ref"><sup>16</sup></xref>, <xref rid="jbmr4102-bib-0046" ref-type="ref"><sup>46</sup></xref>
<sup>)</sup> It is known that oxidative stress and inflammation have a negative impact on muscle health and contribute to sarcopenia,<sup>(</sup>
<xref rid="jbmr4102-bib-0047" ref-type="ref"><sup>47</sup></xref>, <xref rid="jbmr4102-bib-0048" ref-type="ref"><sup>48</sup></xref>
<sup>)</sup> and it has been speculated that to mitigate this damage, cells downregulate metabolism and immune functions that typically produce reactive oxygen species.<sup>(</sup>
<xref rid="jbmr4102-bib-0049" ref-type="ref"><sup>49</sup></xref>
<sup>)</sup>
</p>
              <p>At the background of the rampant negative consequences of spaceflight on healthy rodent quadriceps, there are potentially certain mitigation strategies in effect, again vital information, namely the initiation time of these biofunctions, remained obscure. Activation of the EIF2 network is one such compensating process that facilitates protein synthesis,<sup>(</sup>
<xref rid="jbmr4102-bib-0050" ref-type="ref"><sup>50</sup></xref>
<sup>)</sup> controls mitochondrial dysfunction,<sup>(</sup>
<xref rid="jbmr4102-bib-0051" ref-type="ref"><sup>51</sup></xref>
<sup>)</sup> and promotes the myogenic program.<sup>(</sup>
<xref rid="jbmr4102-bib-0052" ref-type="ref"><sup>52</sup></xref>
<sup>)</sup> In concert, STAT5B, a promoter of muscle growth,<sup>(</sup>
<xref rid="jbmr4102-bib-0053" ref-type="ref"><sup>53</sup></xref>
<sup>)</sup> was found to be upregulated, and significantly activated, as an upstream regulator. A number of genes related to sarcomere architecture are regulated by STAT5B, which by a recent account was shown to facilitate the healing cascade<sup>(</sup>
<xref rid="jbmr4102-bib-0054" ref-type="ref"><sup>54</sup></xref>
<sup>)</sup>; hence, this molecule could be a promising therapeutic target.</p>
              <p>In conclusion, we report a comprehensive genome‐to‐phenome picture of murine quadriceps that have been subjected to ~4 weeks of disuse in spaceflight. Energy deprivation was found at the crossroads of several health deficiencies that have long been linked to spaceflight, such as muscular atrophy, metabolic impairment, and immunodeficiency. Causal relationships between these biofunctions are likely to be achieved in the near future because the process of expanding animal handling capability is underway at the ISS.</p>
            </sec>
            <sec id="jbmr4102-sec-0007">
              <title>Disclosures</title>
              <p>Authors have no conflict of interest.</p>
            </sec>
            <sec id="jbmr4102-sec-0011">
              <title>Peer Review</title>
              <p>The peer review history for this article is available at <ext-link ext-link-type="uri" xlink:href="https://publons.com/publon/10.1002/jbmr.4102">https://publons.com/publon/10.1002/jbmr.4102</ext-link>.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="jbmr4102-supitem-0001">
                <caption>
                  <p>
                    <bold>Supplementary Data</bold>
                  </p>
                </caption>
                <media xlink:href="JBMR-35-2049-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="jbmr4102-supitem-0002">
                <caption>
                  <p><bold>Figure S1.</bold> Quadriceps samples’ quality control check. Post TMM normalization, the normalized counts of individual samples were plotted in the box and whisker plot. Here the box covers the interquartile range (from Q1 to Q3), the middle line across the box represents the mean value and the two ends of the whisker represents the range (from maximum to minimum). The plot shows that TMM normalization achieved a significant homology across the samples from FLT and CTR.</p>
                </caption>
                <media xlink:href="JBMR-35-2049-s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="jbmr4102-supitem-0003">
                <caption>
                  <p><bold>Table S1.</bold> The list of canonical pathways significantly perturbed by differentially expressed genes and metabolites. The list is sorted based on the individual pathway’s z‐score. Pathways that scored a positive z‐score above 1.5 were considered activated; while those pathways, which scored a negative z‐score lower than −1.5 were considered inhibited. There are two activated and 21 inhibited pathways listed in this table. The log transformed p‐values, number of molecules enriching particular pathway and the molecular IDs (gene symbol and metabolite name) are listed as well.</p>
                  <p><bold>Table S2</bold>. The noncanonical networks linked to musculoskeletal operations. Each table includes the gene symbol and gene name, and sorted based on their fold changes transformed to log scale base 2. (A) Protein metabolism network was enriched by 44 upregulated and 53 downregulated biomolecules. The biomolecules included 113 genes and 7 metabolites. (B) Carbohydrate metabolism network was enriched by 47 upregulated and 70 downregulated biomolecules. The biomolecules included 105 genes and 12 metabolites. (C) Lipid metabolism network was enriched by 49 upregulated and 98 downregulated biomolecules. The biomolecules included 119 genes and 28 metabolites. (D) Muscle function network was enriched by 51 upregulated and 60 downregulated biomolecules. The biomolecules included 108 genes and 3 metabolites. The biomolecules included 108 genes and 3 metabolites. The molecules linked to calcium ion (Ca<sup>+2</sup>) channel are highlighted. (E) Inflammation network was enriched by 64 upregulated and 89 downregulated biomolecules. The biomolecules included 114 genes and 39 metabolites. (F) Mitochondrial dysfunction network was enriched by 18 upregulated and 40 downregulated biomolecules. The biomolecules included 42 genes and 16 metabolites.</p>
                  <p><bold>Table S3</bold>. The list of genes associated with the upstream regulators of interest, namely SOCS1, STAT5B, SMAD3, HSF1, mono‐(2‐ethylhexyl) phthalate and PLAU. For individual upstream regulator, the gene symbols were sorted in descending order.</p>
                </caption>
                <media xlink:href="JBMR-35-2049-s003.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="jbmr4102-sec-0008">
              <title>Acknowledgments</title>
              <p>This work was supported in part by NIH T32 DK007519 (to PJC), the Ralph W. and Grace M. Showalter Research Trust Fund (to MAK), the Orthopaedic Trauma Association (to MAK), NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01 AR060863 (to MAK), and GA‐2015‐217 from the Center for the Advancement of Sciences in Space (to MAK). This material is also the result of work supported with resources and the use of facilities at the Richard L. Roudebush VA Medical Center, Indianapolis, IN: VA Merit #BX003751 (to MAK). Additionally, this work was supported by the U.S. Army Medical Research and Materiel Command (to NC, AG, and RH). We thank all of the investigators, staff, and trainees from the Indiana University School of Medicine and U.S. Army that assisted in the Rodent Research 4 spaceflight studies. We also thank the Department of Defense Space Test Program for all of their assistance, especially Carolynn Conley, James Mcleroy, and Perry Ballard. Finally, we thank the entire NASA Rodent Research 4 group, all of the NASA supporting personnel, and the astronauts onboard the ISS (Increment 50). The contents are solely the responsibility of the authors and do not necessarily represent the official views of any of the aforementioned agencies. This material has been reviewed by the Walter Reed Army Institute of Research; there is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense. Research was conducted under an approved animal use protocol in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, NRC Publication, 2011.</p>
              <p>Authors’ roles: RH, MAK, AG and NC conceived the idea; AH, BS, DY, SB, MS, PJC, DW and MAK conducted the animal work; CM, GD, AH and BS performed the assay; NC and RK analyzed the data; NC and MS drafted the first version; NC, MAK, DW and RH edited the texts; all authors read and approved it.</p>
            </ack>
            <ref-list id="jbmr4102-bibl-0001" content-type="cited-references">
              <title>References</title>
              <ref id="jbmr4102-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0001"><string-name><surname>Suetta</surname><given-names>C</given-names></string-name>, <string-name><surname>Frandsen</surname><given-names>U</given-names></string-name>, <string-name><surname>Jensen</surname><given-names>L</given-names></string-name>, et al. <article-title>Aging affects the transcriptional regulation of human skeletal muscle disuse atrophy</article-title>. <source xml:lang="en">PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>12</issue>):<elocation-id>e51238</elocation-id>.<pub-id pub-id-type="pmid">23284670</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0002"><string-name><surname>Giangregorio</surname><given-names>L</given-names></string-name>, <string-name><surname>McCartney</surname><given-names>N</given-names></string-name>. <article-title>Bone loss and muscle atrophy in spinal cord injury: epidemiology, fracture prediction, and rehabilitation strategies</article-title>. <source xml:lang="en">J Spinal Cord Med</source>. <year>2006</year>;<volume>29</volume>(<issue>5</issue>):<fpage>489</fpage>–<lpage>500</lpage>.<pub-id pub-id-type="pmid">17274487</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0003"><string-name><surname>Adams</surname><given-names>GR</given-names></string-name>, <string-name><surname>Caiozzo</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Baldwin</surname><given-names>KM</given-names></string-name>. <article-title>Skeletal muscle unweighting: spaceflight and ground‐based models</article-title>. <source xml:lang="en">J Appl Physiol (1985)</source>. <year>2003</year>;<volume>95</volume>(<issue>6</issue>):<fpage>2185</fpage>–<lpage>201</lpage>.<pub-id pub-id-type="pmid">14600160</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0004"><string-name><surname>Akima</surname><given-names>H</given-names></string-name>, <string-name><surname>Kuno</surname><given-names>S</given-names></string-name>, <string-name><surname>Suzuki</surname><given-names>Y</given-names></string-name>, <string-name><surname>Gunji</surname><given-names>A</given-names></string-name>, <string-name><surname>Fukunaga</surname><given-names>T</given-names></string-name>. <article-title>Effects of 20 days of bed rest on physiological cross‐sectional area of human thigh and leg muscles evaluated by magnetic resonance imaging</article-title>. <source xml:lang="en">J Gravit Physiol</source>. <year>1997</year>;<volume>4</volume>(<issue>1</issue>):<fpage>S15</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">11541171</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0005"><string-name><surname>LeBlanc</surname><given-names>A</given-names></string-name>, <string-name><surname>Lin</surname><given-names>C</given-names></string-name>, <string-name><surname>Shackelford</surname><given-names>L</given-names></string-name>, et al. <article-title>Muscle volume, MRI relaxation times (T2), and body composition after spaceflight</article-title>. <source xml:lang="en">J Appl Physiol</source>. <year>2000</year>;<volume>89</volume>(<issue>6</issue>):<fpage>2158</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">11090562</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0006"><string-name><surname>LeBlanc</surname><given-names>A</given-names></string-name>, <string-name><surname>Rowe</surname><given-names>R</given-names></string-name>, <string-name><surname>Schneider</surname><given-names>V</given-names></string-name>, <string-name><surname>Evans</surname><given-names>H</given-names></string-name>, <string-name><surname>Hedrick</surname><given-names>T</given-names></string-name>. <article-title>Regional muscle loss after short duration spaceflight</article-title>. <source xml:lang="en">Aviat Space Environ Med</source>. <year>1995</year>;<volume>66</volume>(<issue>12</issue>):<fpage>1151</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">8747608</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0007"><string-name><surname>Radugina</surname><given-names>E</given-names></string-name>, <string-name><surname>Almeida</surname><given-names>E</given-names></string-name>, <string-name><surname>Blaber</surname><given-names>E</given-names></string-name>, <string-name><surname>Poplinskaya</surname><given-names>V</given-names></string-name>, <string-name><surname>Markitantova</surname><given-names>Y</given-names></string-name>, <string-name><surname>Grigoryan</surname><given-names>E</given-names></string-name>. <article-title>Exposure to microgravity for 30 days onboard Bion M1 caused muscle atrophy and impaired regeneration in murine femoral quadriceps</article-title>. <source xml:lang="en">Life Sci Space Res</source>. <year>2018</year>;<volume>16</volume>:<fpage>18</fpage>–<lpage>25</lpage>.</mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0008"><string-name><surname>Lloyd</surname><given-names>SA</given-names></string-name>, <string-name><surname>Lang</surname><given-names>CH</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, et al. <article-title>Interdependence of muscle atrophy and bone loss induced by mechanical unloading</article-title>. <source xml:lang="en">J Bone Miner Res</source>. <year>2014</year>;<volume>29</volume>(<issue>5</issue>):<fpage>1118</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">24127218</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0009"><string-name><surname>McKay</surname><given-names>CD</given-names></string-name>, <string-name><surname>Standage</surname><given-names>M</given-names></string-name>. <article-title>Astronaut adherence to exercise‐based reconditioning: psychological considerations and future directions</article-title>. <source xml:lang="en">Musculoskelet Sci Pract</source>. <year>2017</year>;<volume>27</volume>:<fpage>S38</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">28279267</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0010"><string-name><surname>Kramer</surname><given-names>A</given-names></string-name>, <string-name><surname>Green</surname><given-names>J</given-names></string-name>, <string-name><surname>Pollard</surname><given-names>J</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Tugendreich</surname><given-names>S</given-names></string-name>. <article-title>Causal analysis approaches in ingenuity pathway analysis</article-title>. <source xml:lang="en">Bioinformatics</source>. <year>2014</year>;<volume>30</volume>(<issue>4</issue>):<fpage>523</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">24336805</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0011"><string-name><surname>Maupin</surname><given-names>KA</given-names></string-name>, <string-name><surname>Childress</surname><given-names>P</given-names></string-name>, <string-name><surname>Brinker</surname><given-names>A</given-names></string-name>, et al. <article-title>Skeletal adaptations in young male mice after 4 weeks aboard the International Space Station</article-title>. <source xml:lang="en">NPJ Microgravity</source>. <year>2019</year>;<volume>5</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">30623021</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0012">Kamburov A, Cavill R, Ebbels TM, Herwig R, Keun HC. <article-title>Integrated pathway‐level analysis of transcriptomics and metabolomics data with IMPaLA</article-title>. <source xml:lang="en">Bioinformatics</source>. <year>2011</year>;<volume>27</volume>:<fpage>2917</fpage>–<lpage>2918</lpage>.<pub-id pub-id-type="pmid">21893519</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0013">Cavill R, Kamburov A, Blagrove M, Athersuch T, Ellis J, Herwig R, Ebbels T, Keun H. <article-title>Consensus‐phenotype integration of transcriptomic and metabolomic data implies a role for metabolism in the chemosensitivity of tumour cells</article-title>. <source xml:lang="en">PLoS Comput Biol</source>. <year>2011</year>;<volume>7</volume>:<elocation-id>e1001113</elocation-id>.<pub-id pub-id-type="pmid">21483477</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0014"><string-name><surname>Pecaut</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Mao</surname><given-names>XW</given-names></string-name>, <string-name><surname>Bellinger</surname><given-names>DL</given-names></string-name>, et al. <article-title>Is spaceflight‐induced immune dysfunction linked to systemic changes in metabolism?</article-title><source xml:lang="en">PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>5</issue>):<elocation-id>e0174174</elocation-id>.<pub-id pub-id-type="pmid">28542224</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0015"><string-name><surname>Chakraborty</surname><given-names>N</given-names></string-name>, <string-name><surname>Cheema</surname><given-names>A</given-names></string-name>, <string-name><surname>Gautam</surname><given-names>A</given-names></string-name>, et al. <article-title>Gene‐metabolite profile integration to understand the cause of spaceflight induced immunodeficiency</article-title>. <source xml:lang="en">NPJ Microgravity</source>. <year>2018</year>;<volume>4</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">29354685</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0016"><string-name><surname>Chakraborty</surname><given-names>N</given-names></string-name>, <string-name><surname>Gautam</surname><given-names>A</given-names></string-name>, <string-name><surname>Muhie</surname><given-names>S</given-names></string-name>, <string-name><surname>Miller</surname><given-names>S‐A</given-names></string-name>, <string-name><surname>Jett</surname><given-names>M</given-names></string-name>, <string-name><surname>Hammamieh</surname><given-names>R</given-names></string-name>. <article-title>An integrated omics analysis: impact of microgravity on host response to lipopolysaccharide in vitro</article-title>. <source xml:lang="en">BMC Genomics</source>. <year>2014</year>;<volume>15</volume>(<issue>1</issue>):<elocation-id>659</elocation-id>.<pub-id pub-id-type="pmid">25102863</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0017"><string-name><surname>Rizzo</surname><given-names>AM</given-names></string-name>, <string-name><surname>Corsetto</surname><given-names>PA</given-names></string-name>, <string-name><surname>Montorfano</surname><given-names>G</given-names></string-name>, et al. <article-title>Effects of long‐term space flight on erythrocytes and oxidative stress of rodents</article-title>. <source xml:lang="en">PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>3</issue>):<elocation-id>e32361</elocation-id>.<pub-id pub-id-type="pmid">22412864</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0018"><string-name><surname>Stabley</surname><given-names>JN</given-names></string-name>, <string-name><surname>Prisby</surname><given-names>RD</given-names></string-name>, <string-name><surname>Behnke</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Delp</surname><given-names>MD</given-names></string-name>. <article-title>Chronic skeletal unloading of the rat femur: mechanisms and functional consequences of vascular remodeling</article-title>. <source xml:lang="en">Bone</source>. <year>2013</year>;<volume>57</volume>(<issue>2</issue>):<fpage>355</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">24056176</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0019"><string-name><surname>Dadwal</surname><given-names>UC</given-names></string-name>, <string-name><surname>Maupin</surname><given-names>KA</given-names></string-name>, <string-name><surname>Zamarioli</surname><given-names>A</given-names></string-name>, et al. <article-title>The effects of spaceflight and fracture healing on distant skeletal sites</article-title>. <source xml:lang="en">Sci Rep</source>. <year>2019</year>;<volume>9</volume>:<elocation-id>11419</elocation-id>.<pub-id pub-id-type="pmid">31388031</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0020"><string-name><surname>Sandonà</surname><given-names>D</given-names></string-name>, <string-name><surname>Desaphy</surname><given-names>J‐F</given-names></string-name>, <string-name><surname>Camerino</surname><given-names>GM</given-names></string-name>, et al. <article-title>Adaptation of mouse skeletal muscle to long‐term microgravity in the MDS mission</article-title>. <source xml:lang="en">PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>3</issue>):<elocation-id>e33232</elocation-id>.<pub-id pub-id-type="pmid">22470446</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0021"><string-name><surname>Hager</surname><given-names>GL</given-names></string-name>, <string-name><surname>McNally</surname><given-names>JG</given-names></string-name>, <string-name><surname>Misteli</surname><given-names>T</given-names></string-name>. <article-title>Transcription dynamics</article-title>. <source xml:lang="en">Mol Cell</source>. <year>2009</year>;<volume>35</volume>(<issue>6</issue>):<fpage>741</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">19782025</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0022"><string-name><surname>Gambara</surname><given-names>G</given-names></string-name>, <string-name><surname>Salanova</surname><given-names>M</given-names></string-name>, <string-name><surname>Ciciliot</surname><given-names>S</given-names></string-name>, et al. <article-title>Gene expression profiling in slow‐type calf soleus muscle of 30 days space‐flown mice</article-title>. <source xml:lang="en">PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>1</issue>):<elocation-id>e0169314</elocation-id>.<pub-id pub-id-type="pmid">28076365</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0023"><string-name><surname>Stevenson</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Giresi</surname><given-names>PG</given-names></string-name>, <string-name><surname>Koncarevic</surname><given-names>A</given-names></string-name>, <string-name><surname>Kandarian</surname><given-names>SC</given-names></string-name>. <article-title>Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle</article-title>. <source xml:lang="en">J Physiol</source>. <year>2003</year>;<volume>551</volume>(<issue>1</issue>):<fpage>33</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">12844509</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0024"><string-name><surname>Shen</surname><given-names>H</given-names></string-name>, <string-name><surname>Lim</surname><given-names>C</given-names></string-name>, <string-name><surname>Schwartz</surname><given-names>AG</given-names></string-name>, <string-name><surname>Andreev‐Andrievskiy</surname><given-names>A</given-names></string-name>, <string-name><surname>Deymier</surname><given-names>AC</given-names></string-name>, <string-name><surname>Thomopoulos</surname><given-names>S</given-names></string-name>. <article-title>Effects of spaceflight on the muscles of the murine shoulder</article-title>. <source xml:lang="en">FASEB J</source>. <year>2017</year>;<volume>31</volume>(<issue>12</issue>):<fpage>5466</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">28821629</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0025"><string-name><surname>Sun</surname><given-names>Z</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H</given-names></string-name>, et al. <article-title>Simulated microgravity reduces intracellular‐free calcium concentration by inhibiting calcium channels in primary mouse osteoblasts</article-title>. <source xml:lang="en">J Cell Biochem</source>. <year>2019</year>;<volume>120</volume>(<issue>3</issue>):<fpage>4009</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">30260002</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0026"><string-name><surname>Gambara</surname><given-names>G</given-names></string-name>, <string-name><surname>Salanova</surname><given-names>M</given-names></string-name>, <string-name><surname>Ciciliot</surname><given-names>S</given-names></string-name>, et al. <article-title>Microgravity‐induced transcriptome adaptation in mouse paraspinal longissimus dorsi muscle highlights insulin resistance‐linked genes</article-title>. <source xml:lang="en">Front Physiol</source>. <year>2017</year>;<volume>8</volume>:<fpage>279</fpage>.<pub-id pub-id-type="pmid">28529490</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0027"><string-name><surname>Sellers</surname><given-names>JR</given-names></string-name>. <article-title>Myosins: a diverse superfamily</article-title>. <source xml:lang="en">Biochim Biophys Acta</source>. <year>2000</year>;<volume>1496</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">10722873</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0028"><string-name><surname>Thomason</surname><given-names>D</given-names></string-name>, <string-name><surname>Morrison</surname><given-names>P</given-names></string-name>, <string-name><surname>Oganov</surname><given-names>V</given-names></string-name>, <string-name><surname>Ilyina‐Kakueva</surname><given-names>E</given-names></string-name>, <string-name><surname>Booth</surname><given-names>F</given-names></string-name>, <string-name><surname>Baldwin</surname><given-names>K</given-names></string-name>. <article-title>Altered actin and myosin expression in muscle during exposure to microgravity</article-title>. <source xml:lang="en">J Appl Physiol</source>. <year>1992</year>;<volume>73</volume>(<issue>2</issue>):<fpage>S90</fpage>–<lpage>3</lpage>.</mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0029"><string-name><surname>Caiozzo</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Haddad</surname><given-names>F</given-names></string-name>, <string-name><surname>Baker</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Herrick</surname><given-names>RE</given-names></string-name>, <string-name><surname>Prietto</surname><given-names>N</given-names></string-name>, <string-name><surname>Baldwin</surname><given-names>KM</given-names></string-name>. <article-title>Microgravity‐induced transformations of myosin isoforms and contractile properties of skeletal muscle</article-title>. <source xml:lang="en">J Appl Physiol</source>. <year>1996</year>;<volume>81</volume>(<issue>1</issue>):<fpage>123</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">8828654</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0030"><string-name><surname>Perkins</surname><given-names>AD</given-names></string-name>, <string-name><surname>Ellis</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Asghari</surname><given-names>P</given-names></string-name>, <string-name><surname>Shamsian</surname><given-names>A</given-names></string-name>, <string-name><surname>Moore</surname><given-names>ED</given-names></string-name>, <string-name><surname>Tanentzapf</surname><given-names>G</given-names></string-name>. <article-title>Integrin‐mediated adhesion maintains sarcomeric integrity</article-title>. <source xml:lang="en">Dev Biol</source>. <year>2010</year>;<volume>338</volume>(<issue>1</issue>):<fpage>15</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">19879257</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0031"><string-name><surname>Reymann</surname><given-names>AC</given-names></string-name>, <string-name><surname>Boujemaa‐Paterski</surname><given-names>R</given-names></string-name>, <string-name><surname>Martiel</surname><given-names>JL</given-names></string-name>, et al. <article-title>Actin network architecture can determine myosin motor activity</article-title>. <source xml:lang="en">Science</source>. <year>2012</year>;<volume>336</volume>(<issue>6086</issue>):<fpage>1310</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="pmid">22679097</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0032"><string-name><surname>Andreev‐Andrievskiy</surname><given-names>A</given-names></string-name>, <string-name><surname>Popova</surname><given-names>A</given-names></string-name>, <string-name><surname>Boyle</surname><given-names>R</given-names></string-name>, et al. <article-title>Mice in Bion‐M 1 space mission: training and selection</article-title>. <source xml:lang="en">PLoS One</source>. <year>2014</year>;<volume>9</volume>(<issue>8</issue>):<elocation-id>e104830</elocation-id>.<pub-id pub-id-type="pmid">25133741</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0033"><string-name><surname>Porseva</surname><given-names>VV</given-names></string-name>, <string-name><surname>Shilkin</surname><given-names>VV</given-names></string-name>, <string-name><surname>Krasnov</surname><given-names>IB</given-names></string-name>, <string-name><surname>Masliukov</surname><given-names>PM</given-names></string-name>. <article-title>Calbindin‐D28k immunoreactivity in the mice thoracic spinal cord after space flight</article-title>. <source xml:lang="en">Int J Astrobiol</source>. <year>2015</year>;<volume>14</volume>(<issue>4</issue>):<fpage>555</fpage>–<lpage>62</lpage>.</mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0034"><string-name><surname>Wenke</surname><given-names>JC</given-names></string-name>, <string-name><surname>Warren</surname><given-names>GL</given-names></string-name>, <string-name><surname>Rathbone</surname><given-names>CR</given-names></string-name>, <string-name><surname>Armstrong</surname><given-names>RB</given-names></string-name>. <article-title>Mouse plantar flexor muscle size and strength after inactivity and training</article-title>. <source xml:lang="en">Aviat Space Environ Med</source>. <year>2010</year>;<volume>81</volume>(<issue>7</issue>):<fpage>632</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">20597241</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0035"><string-name><surname>Berridge</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Lipp</surname><given-names>P</given-names></string-name>, <string-name><surname>Bootman</surname><given-names>MD</given-names></string-name>. <article-title>The versatility and universality of calcium signalling</article-title>. <source xml:lang="en">Nat Rev Mol Cell Biol</source>. <year>2000</year>;<volume>1</volume>(<issue>1</issue>):<fpage>11</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">11413485</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0036"><string-name><surname>Russell</surname><given-names>AP</given-names></string-name>, <string-name><surname>Foletta</surname><given-names>VC</given-names></string-name>, <string-name><surname>Snow</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Wadley</surname><given-names>GD</given-names></string-name>. <article-title>Skeletal muscle mitochondria: a major player in exercise, health and disease</article-title>. <source xml:lang="en">Biochim Biophys Acta</source>. <year>2014</year>;<volume>1840</volume>(<issue>4</issue>):<fpage>1276</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">24291686</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0037"><string-name><surname>Bonaldo</surname><given-names>P</given-names></string-name>, <string-name><surname>Sandri</surname><given-names>M</given-names></string-name>. <article-title>Cellular and molecular mechanisms of muscle atrophy</article-title>. <source xml:lang="en">Dis Model Mech</source>. <year>2013</year>;<volume>6</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">23268536</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0038"><string-name><surname>Westerblad</surname><given-names>H</given-names></string-name>, <string-name><surname>Bruton</surname><given-names>JD</given-names></string-name>, <string-name><surname>Katz</surname><given-names>A</given-names></string-name>. <article-title>Skeletal muscle: energy metabolism, fiber types, fatigue and adaptability</article-title>. <source xml:lang="en">Exp Cell Res</source>. <year>2010</year>;<volume>316</volume>(<issue>18</issue>):<fpage>3093</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">20580710</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0039"><string-name><surname>Stein</surname><given-names>T</given-names></string-name>, <string-name><surname>Schluter</surname><given-names>M</given-names></string-name>, <string-name><surname>Galante</surname><given-names>A</given-names></string-name>, et al. <article-title>Energy metabolism pathways in rat muscle under conditions of simulated microgravity</article-title>. <source xml:lang="en">J Nutr Biochem</source>. <year>2002</year>;<volume>13</volume>(<issue>8</issue>):<fpage>471</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">12165359</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0040"><string-name><surname>Murray</surname><given-names>PJ</given-names></string-name>. <article-title>The JAK‐STAT signaling pathway: input and output integration</article-title>. <source xml:lang="en">J Immunol</source>. <year>2007</year>;<volume>178</volume>(<issue>5</issue>):<fpage>2623</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">17312100</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0041"><string-name><surname>Chikuma</surname><given-names>S</given-names></string-name>, <string-name><surname>Kanamori</surname><given-names>M</given-names></string-name>, <string-name><surname>Mise‐Omata</surname><given-names>S</given-names></string-name>, <string-name><surname>Yoshimura</surname><given-names>A</given-names></string-name>. <article-title>Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy</article-title>. <source xml:lang="en">Cancer Sci</source>. <year>2017</year>;<volume>108</volume>(<issue>4</issue>):<fpage>574</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">28188673</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0042"><string-name><surname>Malhotra</surname><given-names>N</given-names></string-name>, <string-name><surname>Kang</surname><given-names>J</given-names></string-name>. <article-title>SMAD regulatory networks construct a balanced immune system</article-title>. <source xml:lang="en">Immunology</source>. <year>2013</year>;<volume>139</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">23347175</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0043"><string-name><surname>Shi</surname><given-names>L</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X</given-names></string-name>, et al. <article-title>Pyrroloquinoline quinone protected autophagy‐dependent apoptosis induced by mono (2‐ethylhexyl) phthalate in INS‐1 cells</article-title>. <source xml:lang="en">Hum Exp Toxicol</source>. <year>2020</year>;<volume>39</volume>(<issue>2</issue>):<fpage>194</fpage>–<lpage>211</lpage>.<pub-id pub-id-type="pmid">31661991</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0044"><string-name><surname>Liau</surname><given-names>NP</given-names></string-name>, <string-name><surname>Laktyushin</surname><given-names>A</given-names></string-name>, <string-name><surname>Lucet</surname><given-names>IS</given-names></string-name>, et al. <article-title>The molecular basis of JAK/STAT inhibition by SOCS1</article-title>. <source xml:lang="en">Nat Commun</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">29317637</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0045">
                <label>45</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0045"><string-name><surname>Bousoik</surname><given-names>E</given-names></string-name>, <string-name><surname>Montazeri</surname><given-names>AH</given-names></string-name>. <article-title>“Do we know jack” about JAK? A closer look at JAK/STAT signaling pathway</article-title>. <source xml:lang="en">Front Oncol</source>. <year>2018</year>;<volume>8</volume>:<elocation-id>287</elocation-id>.<pub-id pub-id-type="pmid">30109213</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0046">
                <label>46</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0046"><string-name><surname>Chakraborty</surname><given-names>N</given-names></string-name>, <string-name><surname>Cheema</surname><given-names>A</given-names></string-name>, <string-name><surname>Gautam</surname><given-names>A</given-names></string-name>, et al. <article-title>Gene‐metabolite profile integration to understand the cause of spaceflight induced immunodeficiency</article-title>. <source xml:lang="en">NPJ Microgravity</source>. <year>2018</year>;<volume>4</volume>:<elocation-id>4</elocation-id>.<pub-id pub-id-type="pmid">29387784</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0047">
                <label>47</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0047"><string-name><surname>Powers</surname><given-names>SK</given-names></string-name>, <string-name><surname>Smuder</surname><given-names>A</given-names></string-name>, <string-name><surname>Judge</surname><given-names>A</given-names></string-name>. <article-title>Oxidative stress and disuse muscle atrophy: cause or consequence?</article-title><source xml:lang="en">Curr Opin Clin Nutr Metab Care</source>. <year>2012</year>;<volume>15</volume>(<issue>3</issue>):<fpage>240</fpage>.<pub-id pub-id-type="pmid">22466926</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0048">
                <label>48</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0048"><string-name><surname>Zhang</surname><given-names>P</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X</given-names></string-name>, <string-name><surname>Fan</surname><given-names>M</given-names></string-name>. <article-title>Signaling mechanisms involved in disuse muscle atrophy</article-title>. <source xml:lang="en">Med Hypotheses</source>. <year>2007</year>;<volume>69</volume>(<issue>2</issue>):<fpage>310</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">17376604</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0049">
                <label>49</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0049"><string-name><surname>Forrester</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Kikuchi</surname><given-names>DS</given-names></string-name>, <string-name><surname>Hernandes</surname><given-names>MS</given-names></string-name>, <string-name><surname>Xu</surname><given-names>Q</given-names></string-name>, <string-name><surname>Griendling</surname><given-names>KK</given-names></string-name>. <article-title>Reactive oxygen species in metabolic and inflammatory signaling</article-title>. <source xml:lang="en">Circ Res</source>. <year>2018</year>;<volume>122</volume>(<issue>6</issue>):<fpage>877</fpage>–<lpage>902</lpage>.<pub-id pub-id-type="pmid">29700084</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0050">
                <label>50</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0050"><string-name><surname>Bogorad</surname><given-names>AM</given-names></string-name>, <string-name><surname>Lin</surname><given-names>KY</given-names></string-name>, <string-name><surname>Marintchev</surname><given-names>A</given-names></string-name>. <article-title>Novel mechanisms of eIF2B action and regulation by eIF2α phosphorylation</article-title>. <source xml:lang="en">Nucleic Acids Res</source>. <year>2017</year>;<volume>45</volume>(<issue>20</issue>):<fpage>11962</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">29036434</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0051">
                <label>51</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0051"><string-name><surname>Raini</surname><given-names>G</given-names></string-name>, <string-name><surname>Sharet</surname><given-names>R</given-names></string-name>, <string-name><surname>Herrero</surname><given-names>M</given-names></string-name>, et al. <article-title>Mutant eIF 2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease</article-title>. <source xml:lang="en">J Neurochem</source>. <year>2017</year>;<volume>141</volume>(<issue>5</issue>):<fpage>694</fpage>–<lpage>707</lpage>.<pub-id pub-id-type="pmid">28306143</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0052">
                <label>52</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0052"><string-name><surname>Zismanov</surname><given-names>V</given-names></string-name>, <string-name><surname>Chichkov</surname><given-names>V</given-names></string-name>, <string-name><surname>Colangelo</surname><given-names>V</given-names></string-name>, et al. <article-title>Phosphorylation of eIF2α is a translational control mechanism regulating muscle stem cell quiescence and self‐renewal</article-title>. <source xml:lang="en">Cell Stem Cell</source>. <year>2016</year>;<volume>18</volume>(<issue>1</issue>):<fpage>79</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">26549106</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0053">
                <label>53</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0053"><string-name><surname>Paul</surname><given-names>RG</given-names></string-name>, <string-name><surname>Hennebry</surname><given-names>AS</given-names></string-name>, <string-name><surname>Elston</surname><given-names>MS</given-names></string-name>, <string-name><surname>Conaglen</surname><given-names>JV</given-names></string-name>, <string-name><surname>McMahon</surname><given-names>CD</given-names></string-name>. <article-title>Regulation of murine skeletal muscle growth by STAT5B is age‐and sex‐specific</article-title>. <source xml:lang="en">Skelet Muscle</source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>19</fpage>.<pub-id pub-id-type="pmid">31230596</pub-id></mixed-citation>
              </ref>
              <ref id="jbmr4102-bib-0054">
                <label>54</label>
                <mixed-citation publication-type="journal" id="jbmr4102-cit-0054"><string-name><surname>Gilbert</surname><given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>R</given-names></string-name>, <string-name><surname>Denson</surname><given-names>L</given-names></string-name>, et al. <article-title>Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase‐mediated loss of barrier function and inflammation</article-title>. <source xml:lang="en">EMBO Mol Med</source>. <year>2012</year>;<volume>4</volume>(<issue>2</issue>):<fpage>109</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">22228679</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
